Analyst Consensus ?
ConsensusBuy47 ratings
Bullish2961.7%
Neutral1531.9%
Bearish36.4%
The Coca-Cola Company · KO · FY2025 Q3 · Calendar Q4 2025
Coca-Cola keeps guidance intact as innovation and refranchising support growth
The current call supports a constructive but qualified view: resilient organic growth, maintained guidance, brand investment, and refranchising progress support the case for continued earnings growth, while volume execution, currency, inflation, regulatory changes, and competition remain material tests.
Reported Before market openNYSEConsumer Defensive
$368.51B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.82
Consensus $0.78
EPS surprise
+5.3%
Reported versus consensus
Reported revenue
$12.46B
Consensus $12.41B
Revenue surprise
+0.4%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+4.1%
Event window
SPY move
-0.0%
Same window
Abnormal move
+4.1%
Stock minus SPY
Volume
2.3×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
KOSPY benchmark
Ask FN2 about KO FY2025 Q3
Transcript, numbers and history already loaded
Why did KO rise 4.1% after beating EPS estimates in FY2025 Q3?What changed in KO's guidance and outlook in FY2025 Q3?Give me the bull and bear case for KO after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, the company reported another quarter of organic growth and maintained its outlook while adding detail on refranchising progress, new product initiatives, early observations around GLP-1-related demand, and the 2026 capacity ramp for Fairlife and Core Power.
Guidance delta
Maintained: management said 2025 guidance remains on track for 5–6% organic revenue growth, approximately 8% comparable EPS growth, and at least $9.8 billion in free cash flow.
Key takeaways
- Management described Q3 organic revenue growth of 6% and comparable EPS growth of 6% despite currency headwinds.
- The company highlighted progress on refranchising, including transactions in India and Africa, as a route to system efficiency and growth.
- Brand marketing and product innovation remain central, with Sprite + Tea, BACARDÍ mixed drinks, retro Diet Coke variants, and coffee initiatives in the pipeline.
- Fairlife and Core Power capacity expansion is expected to support the portfolio as new capacity ramps in 2026.
- The main counterweights are inflation, trade and currency volatility, regulatory changes, and potentially slower volume growth against tougher comparisons.
Management priorities
- Build billion-dollar brands through marketing transformation, digital consumer engagement, and product innovation.
- Advance refranchising and bottler-governance initiatives in India and Africa.
- Invest in AI and productivity initiatives, while expanding Fairlife and Core Power capacity.
Follow KO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$85.65Current
$60Low
$79.79Average
$104High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Sep 28, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 30, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 29, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 29, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 29, 2026 |
| UBS | Buy | Buy | Maintain | Jul 16, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 29, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 30, 2026 |
| Freedom Broker | Hold | Hold | Maintain | Oct 31, 2025 |
| BNP Paribas | Outperform | Outperform | Maintain | Jul 21, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 9, 2025 |
| Truist Securities | Buy | Buy | Maintain | Oct 16, 2024 |
| CFRA | Hold | Buy | Downgrade | Sep 5, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Jul 27, 2023 |
| HSBC | Buy | Buy | Maintain | Jun 7, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 3, 2022 |
| DZ Bank | Hold | Buy | Downgrade | Apr 28, 2022 |
| Guggenheim | Buy | Buy | Maintain | Apr 26, 2022 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Apr 26, 2022 |
| DA Davidson | Perform | Peer Perform | Maintain | Apr 13, 2021 |
| Bernstein | Outperform | Outperform | Maintain | Jan 20, 2021 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 1, 2020 |
| BMO Capital | Market Perform | Market Perform | Maintain | Oct 21, 2019 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jul 29, 2019 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bank of America | Buy | Buy | Maintain | Oct 9, 2017 |
| Daiwa Capital | Outperform | Outperform | Maintain | Jun 13, 2017 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Sep 29, 2016 |
| Stifel | Hold | Buy | Downgrade | Sep 29, 2016 |
| Susquehanna | Neutral | Neutral | Maintain | Mar 15, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Feb 26, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Feb 26, 2016 |
| Tigress Financial | Neutral | Buy | Downgrade | Dec 4, 2015 |
| Nomura | Buy | Buy | Maintain | Dec 15, 2014 |
| Societe Generale | Sell | Hold | Downgrade | Oct 22, 2014 |
| Brasil Plural | Overweight | Overweight | Maintain | Aug 25, 2014 |
| Janney Capital | Buy | Buy | Maintain | Dec 12, 2013 |
| Standpoint Research | Sell | Sell | Maintain | Dec 2, 2013 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Sep 19, 2013 |
| CLSA | Underperform | Outperform | Downgrade | Sep 3, 2013 |
| Davenport | Neutral | Buy | Downgrade | Apr 12, 2013 |
| Credit Agricole | Outperform | Underperform | Upgrade | Mar 14, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $85.65. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Seaport Global | Analyst unavailable | $95 | $87.76 | +10.9% | Aug 14, 2026 |
| Barclays | Lauren Lieberman | $93 | $89.08 | +8.6% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $96 | $90.39 | +12.1% | Jul 29, 2026 |
| UBS | Peter Grom | $104 | $90.12 | +21.4% | Jul 29, 2026 |
| Piper Sandler | Analyst unavailable | $95 | $88.27 | +10.9% | Jul 29, 2026 |
| Jefferies | Kaumil Gajrawala | $104 | $88.27 | +21.4% | Jul 29, 2026 |
| Wells Fargo | Analyst unavailable | $95 | $88.27 | +10.9% | Jul 29, 2026 |
| Bernstein | Cristian Rios | $93 | $88.27 | +8.6% | Jul 29, 2026 |
| Morgan Stanley | Dara Mohsenian | $100 | $88.27 | +16.8% | Jul 29, 2026 |
| Goldman Sachs | Analyst unavailable | $86 | $88.27 | +0.4% | Jul 28, 2026 |
| Evercore ISI | Analyst unavailable | $100 | $88.29 | +16.8% | Jul 28, 2026 |
| Barclays | Lauren Lieberman | $91 | $82.12 | +6.2% | Jul 21, 2026 |
| UBS | Peter Grom | $98 | $84.57 | +14.4% | Jul 16, 2026 |
| Bernstein | Analyst unavailable | $83 | $82.46 | -3.1% | Jul 9, 2026 |
| Truist Financial | Analyst unavailable | $88 | $81.42 | +2.7% | Jun 26, 2026 |
| Bernstein | Cristian Rios | $84 | $82.53 | -1.9% | Jun 11, 2026 |
| Morgan Stanley | Dara Mohsenian | $89 | $81.34 | +3.9% | Jun 10, 2026 |
| Barclays | Analyst unavailable | $89 | $81.55 | +3.9% | May 21, 2026 |
| Barclays | Analyst unavailable | $85 | $78.87 | -0.8% | Apr 30, 2026 |
| Morgan Stanley | Analyst unavailable | $88 | $77.58 | +2.7% | Mar 11, 2026 |
| Barclays | Analyst unavailable | $83 | $79.56 | -3.1% | Feb 12, 2026 |
| Truist Financial | Analyst unavailable | $85 | $78.32 | -0.8% | Feb 11, 2026 |
| UBS | Analyst unavailable | $87 | $78.17 | +1.6% | Feb 11, 2026 |
| Morgan Stanley | Analyst unavailable | $87 | $77.33 | +1.6% | Feb 11, 2026 |
| RBC Capital | Nik Modi | $87 | $78.27 | +1.6% | Feb 11, 2026 |
| Evercore ISI | Analyst unavailable | $85 | $77.66 | -0.8% | Feb 11, 2026 |
| RBC Capital | Nik Modi | $78 | $78.52 | -8.9% | Feb 6, 2026 |
| UBS | Peter Grom | $82 | $76.96 | -4.3% | Feb 3, 2026 |
| Deutsche Bank | Analyst unavailable | $83 | $73.52 | -3.1% | Jan 29, 2026 |
| Barclays | Lauren Lieberman | $77 | $70.4 | -10.1% | Oct 23, 2025 |
| Piper Sandler | Analyst unavailable | $81 | $71.22 | -5.4% | Oct 22, 2025 |
| Evercore ISI | Analyst unavailable | $82 | $71.22 | -4.3% | Oct 21, 2025 |
| RBC Capital | Nik Modi | $76 | $70.44 | -11.3% | Jul 21, 2025 |
| Jefferies | Kaumil Gajrawala | $77 | $68.01 | -10.1% | Oct 24, 2024 |
| CFRA | Garrett Nelson | $70 | $67.6 | -18.3% | Oct 23, 2024 |
| Morgan Stanley | Dara Mohsenian | $78 | $70.84 | -8.9% | Aug 27, 2024 |
| Truist Financial | Bill Chappell | $70 | $65.81 | -18.3% | Jul 25, 2024 |
| Argus Research | Christopher Graja | $72 | $62.94 | -15.9% | May 22, 2024 |
| D.A. Davidson | Linda Bolton Weiser | $81 | $28.7 | -5.4% | Nov 21, 2023 |
| Bernstein | Callum Elliott | $66 | $63.98 | -22.9% | Apr 25, 2023 |
| Morgan Stanley | Dara Mohsenian | $70 | $60.36 | -18.3% | Mar 7, 2023 |
| Wells Fargo | Chris Carey | $70 | $60.6 | -18.3% | Feb 14, 2023 |
| Deutsche Bank | Analyst unavailable | $62 | $63.68 | -27.6% | Dec 6, 2022 |
| Wedbush | Gerald Pascarelli | $63 | $54.39 | -26.4% | Oct 10, 2022 |
| HSBC | Analyst unavailable | $76 | $61.15 | -11.3% | Sep 6, 2022 |
| Deutsche Bank | Analyst unavailable | $65 | $62.51 | -24.1% | Jul 27, 2022 |
| UBS | Analyst unavailable | $72 | $63.21 | -15.9% | Jul 27, 2022 |
| Truist Financial | Bill Chappell | $75 | $65.56 | -12.4% | Apr 27, 2022 |
| Wells Fargo | Chris Carey | $74 | $66.15 | -13.6% | Apr 27, 2022 |
| Guggenheim | Analyst unavailable | $71 | $65.46 | -17.1% | Apr 26, 2022 |
| Deutsche Bank | Analyst unavailable | $64 | $65.81 | -25.3% | Apr 26, 2022 |
| Credit Suisse | Analyst unavailable | $68 | $65.81 | -20.6% | Apr 26, 2022 |
| HSBC | Analyst unavailable | $72 | $65.57 | -15.9% | Apr 26, 2022 |
| Citigroup | Analyst unavailable | $68 | $65.94 | -20.6% | Apr 26, 2022 |
| Cowen & Co. | Vivien Azer | $68 | $65.8 | -20.6% | Apr 26, 2022 |
| Credit Suisse | Kaumil Gajrawala | $68 | $65.05 | -20.6% | Apr 26, 2022 |
| Bank of America Securities | Bryan Spillane | $70 | $65.94 | -18.3% | Apr 25, 2022 |
| Guggenheim | Laurent Grandet | $71 | $65.94 | -17.1% | Apr 25, 2022 |
| CFRA | Garrett Nelson | $72 | $65.94 | -15.9% | Apr 25, 2022 |
| Cowen & Co. | Vivien Azer | $68 | $65.94 | -20.6% | Apr 25, 2022 |
| J.P. Morgan | Andrea Faria Teixeira | $73 | $65.25 | -14.8% | Apr 22, 2022 |
| Credit Suisse | Kaumil Gajrawala | $66 | $66.21 | -22.9% | Apr 21, 2022 |
| Evercore ISI | Robert Ottenstein | $70 | $62.54 | -18.3% | Feb 21, 2022 |
| Morgan Stanley | Dara Mohsenian | $76 | $60.29 | -11.3% | Feb 13, 2022 |
| UBS | Sean King | $68 | $59.83 | -20.6% | Feb 11, 2022 |
| Goldman Sachs | Bonnie Herzog | $60 | $60.91 | -29.9% | Feb 10, 2022 |
| Guggenheim | Laurent Grandet | $67 | $60.91 | -21.8% | Feb 10, 2022 |
| Credit Suisse | Kaumil Gajrawala | $66 | $59.15 | -22.9% | Jan 26, 2022 |
| CFRA | Garrett Nelson | $68 | $59.83 | -20.6% | Jan 4, 2022 |
| Bank of America Securities | Bryan Spillane | $64 | $55.19 | -25.3% | Jul 22, 2021 |
| Cowen & Co. | Vivien Azer | $60 | $55.27 | -29.9% | Jul 21, 2021 |
| Argus Research | Chris Graja | $63 | $53.71 | -26.4% | Jun 17, 2021 |
| DZ BANK AG | Axel Herlinghaus | $60 | $52.98 | -29.9% | Apr 21, 2021 |
Track every rating change on KO the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe Coca-Cola Company, a beverage company, manufactures and sells various nonalcoholic beverages in the United States and internationally. The company provides Trademark Coca-Cola, sparkling soft drinks and flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and emerging beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers comprising restaurants and convenience stores.…
Historical context
All KO earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MKC McCormick & Company, Incorporated | FY2026 Q3 · Calendar Q4 2026 | +13.9% | -4.9% | McCormick reports strong Q3 growth while U.S. volumes remain soft |
| CAG Conagra Brands, Inc. | FY2027 Q1 · Calendar Q3 2026 | +44.4% | -4.9% | Conagra maintains outlook while increasing brand investment and simplifying SKUs |
| COST Costco Wholesale Corporation | FY2026 Q4 · Calendar Q3 2026 | +3.2% | +2.9% | Costco’s growth broadens as warehouses and digital sales accelerate |
| GIS General Mills, Inc. | FY2027 Q1 · Calendar Q3 2026 | +4.6% | +1.0% | General Mills leans on mix, innovation and e-commerce amid pressure |
| KR The Kroger Co. | FY2026 Q2 · Calendar Q3 2026 | +2.8% | +2.7% | Kroger: Strong digital growth offsets softer sales outlook |
| CPB Campbell Soup Company | FY2026 Q4 · Calendar Q3 2026 | +1.1% | -7.0% | Campbell’s leans on savings and innovation amid pressured demand |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the KO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-03T18:00:49.337887+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T18:00:49.335223+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.